Cyta Therapeutics, Inc
Cyta Therapeutics, Inc. is an early-stage life sciences company based in Woburn, MA, focused on developing proprietary products for the treatment of obesity and related metabolic conditions. The company's lead development program, Cyta001, utilizes a novel polymer-based nanogel technology called IntelliGel to deliver a potent thyromimetic drug, targeting liver cells to reverse body weight gain and improve metabolic parameters.
Founded on innovative research from the University of Massachusetts Amherst, Cyta aims to address the global obesity epidemic affecting over 650 million people. With a strong team and a commitment to advancing its therapeutic pipeline, Cyta Therapeutics seeks partnerships to enhance its drug delivery solutions and improve therapeutic outcomes for chronic medical conditions linked to obesity.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.

